IN2014MN01513A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01513A
IN2014MN01513A IN1513MUN2014A IN2014MN01513A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A IN 1513MUN2014 A IN1513MUN2014 A IN 1513MUN2014A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A
Authority
IN
India
Prior art keywords
subject
allergic
peptides
timothy grass
methods
Prior art date
Application number
Other languages
English (en)
Inventor
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Original Assignee
Jolla Inst Allergy Immunolog
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Inst Allergy Immunolog, Alessandro Sette, Veronique Schulten, Howard Grey, Bjoern Peters, Jason Greenbaum filed Critical Jolla Inst Allergy Immunolog
Publication of IN2014MN01513A publication Critical patent/IN2014MN01513A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
IN1513MUN2014 2012-02-07 2013-02-07 IN2014MN01513A (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US201261734886P 2012-12-07 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (1)

Publication Number Publication Date
IN2014MN01513A true IN2014MN01513A (https=) 2015-09-11

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1513MUN2014 IN2014MN01513A (https=) 2012-02-07 2013-02-07

Country Status (13)

Country Link
US (1) US10428124B2 (https=)
EP (1) EP2812026A4 (https=)
JP (1) JP2015513527A (https=)
KR (1) KR20140129124A (https=)
CN (1) CN104203277A (https=)
AU (1) AU2013216993C1 (https=)
BR (1) BR112014019504A2 (https=)
CA (1) CA2864084A1 (https=)
EA (1) EA201491481A1 (https=)
HK (1) HK1204929A1 (https=)
IN (1) IN2014MN01513A (https=)
MX (1) MX2014009285A (https=)
WO (1) WO2013119863A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
AU2014352986A1 (en) 2013-11-20 2016-06-16 Alk-Abello A/S Pan pollen immunogens and methods and uses thereof for immune response modulation
BR112016011930A2 (pt) 2013-12-23 2017-09-26 Alk Abello As combinações de peptídeos e seus usos em tratamento de alergia de ácaro de poeira
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
EP3925968A3 (en) 2014-10-07 2022-03-02 Cytlimic Inc. Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
CN113388021A (zh) 2015-03-09 2021-09-14 Cytlimic公司 源于gpc3的肽、使用其的医药组合物、免疫诱导剂、及抗原呈递细胞的制造方法
RU2709015C2 (ru) 2015-04-07 2019-12-13 Ситлимик Инк. Лекарственное средство
CA3023092A1 (en) * 2016-05-03 2017-11-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to induce tolerance
US11291718B2 (en) 2016-10-11 2022-04-05 Cytlimic Inc. Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
CN119086940A (zh) * 2017-04-28 2024-12-06 朋友股份有限公司 变态反应的抗原及其表位
JP7770314B2 (ja) * 2019-11-25 2025-11-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 診断及び処置のための抗原ニューロン特異的エノラーゼペプチド
CN120349374B (zh) * 2025-03-25 2025-10-10 长沙理工大学 一种米渣短肽及其在降尿酸中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
EP2392591B1 (de) * 2002-06-25 2018-02-21 Merck Patent GmbH DNA-Sequenz und rekombinante Herstellung des Graspollen-Allergens Phl p 4
RU2323942C2 (ru) 2002-08-19 2008-05-10 Мерк Патент Гмбх ВАРИАНТЫ ОСНОВНОГО АЛЛЕРГЕНА Phl p 1 ИЗ ТИМОФЕЕВКИ ЛУГОВОЙ
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
AU2006204997B2 (en) 2005-01-12 2011-09-01 Monsanto Technology, Llc Genes and uses for plant improvement
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
PL2244734T3 (pl) * 2008-02-01 2017-01-31 Murdoch Childrens Research Institute Sposób indukcji tolerancji na alergen
EP2388268A1 (en) * 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
US20120100163A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
US20120100164A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
US9700071B2 (en) * 2012-03-26 2017-07-11 Axcella Health Inc. Nutritive fragments, proteins and methods
JP2015514126A (ja) 2012-04-16 2015-05-18 アルク−アベッロ エイ/エスAlk−Abello A/S 非特異的アレルギー免疫療法において使用するための植物プロフィリンポリペプチド

Also Published As

Publication number Publication date
EA201491481A1 (ru) 2014-11-28
BR112014019504A2 (pt) 2017-06-27
CN104203277A (zh) 2014-12-10
US10428124B2 (en) 2019-10-01
JP2015513527A (ja) 2015-05-14
US20150023992A1 (en) 2015-01-22
HK1204929A1 (en) 2015-12-11
EP2812026A4 (en) 2016-04-27
CA2864084A1 (en) 2013-08-15
EP2812026A1 (en) 2014-12-17
MX2014009285A (es) 2015-02-04
AU2013216993B2 (en) 2016-09-15
KR20140129124A (ko) 2014-11-06
AU2013216993C1 (en) 2017-01-19
WO2013119863A1 (en) 2013-08-15
AU2013216993A1 (en) 2014-08-21

Similar Documents

Publication Publication Date Title
IN2014MN01513A (https=)
CA2863861A1 (en) Epitopes from allergen proteins and methods and uses for immune response modulation
MX2019011952A (es) Proteina anti-garp y sus usos.
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
SG194755A1 (en) Pre-fusion rsv f antigens
EA201590451A1 (ru) Способ лечения меланомы с применением вируса простого герпеса и ингибитора иммунной контрольной точки
SG11201505480SA (en) Amino acid and protein hydrolysate based formulas with a stable emulsion system
EA201790109A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
BR112013020500A8 (pt) anticorpo isolado, recombinante ou purificado
MX2021006017A (es) Polipeptidos de folistatina y sus usos.
BR112015013127A2 (pt) imunoterapia com agentes de ligação
WO2011113019A3 (en) Ctla4 proteins and their uses
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
BR112014033116A2 (pt) anticorpos para tau
IN2014CN04498A (https=)
ZA201502991B (en) Disubstituted amino acids and methods of preparation and use thereof
EP3087185A4 (en) Antibodies comprising c-terminal light chain polypeptide extensions and conjugates and methods of use thereof
PH12014502352A1 (en) Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos
PH12015501870B1 (en) Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
HK1223298A1 (zh) 预防和治疗组织损伤相关疾病和病症的组织保护肽和肽类似物
WO2013095091A3 (en) Rsv g protein specific antibodies
EP2552462A4 (en) CCN3 THERAPEUTIC PEPTIDES AND THEIR ANALOGS
WO2013006050A9 (en) Peptides inducing or enhancing an immune response against prostate-specific membrane protein (psma)
WO2013166453A3 (en) T cell epitopes from cockroach and methods of making and using same